High risk human papillomavirus in women with normal cervical cytology prior to the development of abnormal cytology and colposcopy

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 107, Issue 5, 2000, Pages 600-604

  Hopman, E H ^a   Rozendaal, L ^a   Voorhorst, F J ^a   Walboomers, J M M ^a   Kenemans, P ^a   Helmerhorst, Th J M ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COLPOSCOPY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; NORMAL HUMAN; PAPANICOLAOU TEST; PAPILLOMA VIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK ASSESSMENT; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DYSPLASIA; VIRUS INFECTION;

ADOLESCENT; ADULT; CERVIX UTERI; COLPOSCOPY; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PROSPECTIVE STUDIES; RISK FACTORS; VAGINAL SMEARS;

EID: 0034054638     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2000.tb13299.x     Document Type: Article

References (14)

1. IARC Working Group, Human Papillomaviruses. IARC Scientific Publication, No. 64, IARC, Lyon, 1995.
2. Bosch FX, Munoz N, Manos MM et al. Prevalence of human papillo-mavirus in cervical smears: a worldwide perspective. J Natl Cancer Inst 1995; 87: 796–802.
3. Schiffmann MH, Bauer HM, Hoover RN et al. Epidemiological evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993; 85: 958–964.
4. Kjaer SK, van den Brule AJC, Bock JE et al. Human papillomavirus—the most significant risk determinant of cervical intraepithelial neoplasia. Int J Cancer 1996; 65: 601–606.
5. Nobbenhuis MAE, Walboomers JMM, Helmerhorst ThJM et al. Relation of human papillomavirus status to cervical lesions and consequences for cervical cancer screening: a prospective study. Lancet 1999; 354: 20–25.
6. Rozendaal L, Walboomers JMM, van der Linden JC et al. PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears. Int J Cancer 1996; 68: 766–769.
7. de Roda Husman AM, Walboomers JMM, van den Brule AJC, Meijer CJLM, Snijders PJF. The use of general primers GP5 and GP6 elongated at their 3'ends with adjacent highly conserved sequences improves human papillomavirus detection by polymerase chain reaction. J Gen Virol 1995; 76: 1057–1062.
8. Jacobs MV, Snijders PJF, van den Brule AJC, Helmerhorst ThJM, Meijer CJLM, Walboomers JMM. A general primer GP5+/6+ mediated PCR-enzyme immunoassay method for rapid detection of 14 high risk and 6 low risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol 1997; 3: 791–795.
9. Ho GYF, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998; 338: 423–428.
10. Koutsky LA, Holmes KK, Critchlow CW et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992; 327: 1272–1278.
11. Melkert PWJ, Hopman EH, van den Brule AJC et al. Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent. Int J Cancer 1993; 53: 919–923.
12. Hollingworth A, Barton SE, Jenkins D, Cuzich J, Singer A. Colposcopy of women with cervical HPV type 16 infection but normal cytology. Lancet 1987; 2: 1148.
13. Schneider A, Sterzik K, Buck G, De Villiers EM. Colposcopy is superior to cytology for the detection of early genital human papillomavirus infection. Obstet Gynecol 1988; 71: 236–241.
14. Barasso R, Coupez F, Ionesco M, De Brux J. Human papillomaviruses and cervical intraepithelial neoplasia: the role of colposcopy. Gynecol Oncol 1987; 27: 197–207.